AIRP (Autorité Ivoirienne de Régulation Pharmaceutique) current fee schedule, reviewed for 2026, in XOF.
22 fee lines100% exact amountscurrency XOFFX rates 2026-09-17reviewed 2026-09-16
| Fee line | Official amount | USD equivalent | Frequency | Provenance |
|---|---|---|---|---|
| Prior declaration (listing) of medical devices and DMDIV, any class Tariff row « Déclaration des dispositifs médicaux / DMDIV »; the schedule carries XOF 10,000 in every column. Section I makes the declaration compulsory for every supply-chain actor whatever the device class. | XOF 10,000 | $17.54 | Per product | Verified |
| Marketing authorisation (Autorisation de Commercialisation) — Class A device, registration (redevance de base) Tariff row « Enregistrement (Redevance de base) », Classe A (I) column. | XOF 50,000 | $87.69 | Per product | Verified |
| Marketing authorisation — Class B device, registration (redevance de base) Tariff row « Enregistrement (Redevance de base) », Classe B (IIA) column. | XOF 250,000 | $438 | Per product | Verified |
| Marketing authorisation — Class C device, registration (redevance de base) Tariff row « Enregistrement (Redevance de base) », Classe C (IIB) column. | XOF 500,000 | $877 | Per product | Verified |
| Marketing authorisation — Class D device, registration (redevance de base) Tariff row « Enregistrement (Redevance de base) », Classe D (III) column. | XOF 1,000,000 | $1,754 | Per product | Verified |
| Marketing authorisation — DMDIV, registration (redevance de base) The fifth and highest tariff column, headed « DMDIV de Classe D (III) », carries XOF 2,500,000 for registration, the same as the four medical-device columns for a major variation. | XOF 2,500,000 | $4,384 | Per product | Verified |
| Marketing authorisation — Class A device, major variation Tariff row « Variation majeure », Classe A (I) column — same amount as Class A registration. | XOF 50,000 | $87.69 | Per variation | Verified |
| Marketing authorisation — Class B device, major variation Tariff row « Variation majeure », Classe B (IIA) column. | XOF 250,000 | $438 | Per variation | Verified |
| Marketing authorisation — Class C device, major variation Tariff row « Variation majeure », Classe C (IIB) column. | XOF 500,000 | $877 | Per variation | Verified |
| Marketing authorisation — Class D device, major variation Tariff row « Variation majeure », Classe D (III) column. | XOF 1,000,000 | $1,754 | Per variation | Verified |
| Marketing authorisation — DMDIV, major variation Tariff row « Variation majeure », « DMDIV de Classe D (III) » column. | XOF 2,500,000 | $4,384 | Per variation | Verified |
| Marketing authorisation — Class A device, minor variation Tariff row « Variation mineure », Classe A (I) column. | XOF 10,000 | $17.54 | Per variation | Verified |
| Marketing authorisation — Class B device, minor variation Tariff row « Variation mineure », Classe B (IIA) column. | XOF 25,000 | $43.84 | Per variation | Verified |
| Marketing authorisation — Class C device, minor variation Tariff row « Variation mineure », Classe C (IIB) column. | XOF 50,000 | $87.69 | Per variation | Verified |
| Marketing authorisation — Class D device, minor variation Tariff row « Variation mineure », Classe D (III) column. | XOF 100,000 | $175 | Per variation | Verified |
| Marketing authorisation — DMDIV, minor variation Tariff row « Variation mineure », « DMDIV de Classe D (III) » column. | XOF 250,000 | $438 | Per variation | Verified |
| Marketing authorisation — Class A device, renewal (renouvellement) Tariff row « Renouvellement », Classe A (I) column; the Autorisation de Commercialisation is "valable pour une période de cinq (5) ans renouvelables". | XOF 25,000 | $43.84 | Per product, every 5 years | Verified |
| Marketing authorisation — Class B device, renewal (renouvellement) Tariff row « Renouvellement », Classe B (IIA) column. | XOF 125,000 | $219 | Per product, every 5 years | Verified |
| Marketing authorisation — Class C device, renewal (renouvellement) Tariff row « Renouvellement », Classe C (IIB) column. | XOF 250,000 | $438 | Per product, every 5 years | Verified |
| Marketing authorisation — Class D device, renewal (renouvellement) Tariff row « Renouvellement », Classe D (III) column. | XOF 500,000 | $877 | Per product, every 5 years | Verified |
| Marketing authorisation — DMDIV, renewal (renouvellement) Tariff row « Renouvellement », « DMDIV de Classe D (III) » column. | XOF 1,250,000 | $2,192 | Per product, every 5 years | Verified |
| Declaration of medical-biology laboratory reagents Tariff row « Déclaration des réactifs de laboratoire de biologie médicale », a single amount spanning the schedule rather than a per-class column. | XOF 10,000 | $17.54 | Per product | Verified |
- Amounts are in CFA francs (XOF), which has no subunit; the schedule publishes whole francs, and the dossier requires the attestation de Prix Grossiste Hors Taxe "en francs CFA".
- The source's effectiveDate is the date the procedure carries on its cover, "Abidjan, le 26.05.2023" (document N° 0970/AIRP); the schedule states no separate entry-into-force clause, so no later date is asserted.
- "Le montant de la redevance de base est réduit de moitié pour les Dispositifs Médicaux fabriqués dans l'espace UEMOA" — the halving applies to the registration base fee, so a device manufactured inside the UEMOA area pays half the Classe A-D and DMDIV registration amounts above.
- The schedule's five columns are headed « Classe A (I) », « Classe B (IIA) », « Classe C (IIB) », « Classe D (III) » and « DMDIV de Classe D (III) »: the AIRP's own tariff therefore maps the Ivorian device classes A to D onto the EU classes I, IIA, IIB and III, and prices a single DMDIV column, for the Class D DMDIV. The procedure prices no other DMDIV class, and whether a Class A, B or C DMDIV is charged the Class D column is not stated.
- lowRiskLocal is the Class A enregistrement amount (XOF 50,000) and highRiskLocal spans the Class D enregistrement amount (XOF 1,000,000) to the « DMDIV de Classe D (III) » column (XOF 2,500,000); the declaration fee of XOF 10,000 sits below both and is stated as its own row.
- Payment is "par un chèque bancaire barré à l'ordre de : « AUTORITÉ IVOIRIENNE DE REGULATION PHARMACEUTIQUE »", and the file requires "l'original du chèque plus trois (3) copies".
- A second, unquantified cost sits behind the fixed tariff: "Sur avis du comité d'expert, une évaluation technique supplémentaire peut être requise. Dans ce cas, les frais d'évaluation seront fixés en fonction du protocole d'évaluation requis. Ces frais d'évaluation seront à la charge du demandeur" — a quote-required amount with no published figure.
- Two other Ivorian device-related charges exist in law without a published amount in the instruments read: the ARTCI homologation droit of art. 88 of ordonnance n° 2012-293, left to an arrêté conjoint of the ministers of Economy/Finance and Telecommunications/TIC, and the ARSN dossier-study, renewal and modification fees of arts. 16, 21, 38 and 41 of décision n° 000010 ARSN/DG du 6 janvier 2026, which refer to "la réglementation en vigueur" without amounts.
Keep researching this market
More Côte d'Ivoire medical device resources
Continue with this market
Exact amounts verified against the AIRP (Autorité Ivoirienne de Régulation Pharmaceutique) fee schedule · full review 2026-09-16 · row IDs are stable — cite as government-fees:cote-divoire:declaration-dispositifs-medicaux-dmdiv